Elanco Animal Health (ELAN) Other financing activities (2017 - 2026)

Elanco Animal Health has reported Other financing activities for 10 years, with the latest figure at -$15.0 million in Q1 2026.

• Quarterly Other financing activities fell 114.29% year-over-year to -$15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.0 million (changed 0.0% YoY) and the FY2025 annual result came in at -$2.0 million, up 88.24% from the prior year.
• Other financing activities grew to -$15.0 million in Q1 2026 per ELAN's latest filing, from -$17.0 million in the prior quarter.
• Over five years, Other financing activities peaked at $35.0 million in Q3 2025 and troughed at -$17.0 million in Q4 2025.
• A 5-year average of -$4.5 million and a median of -$7.0 million in 2023 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 537.5% in 2025, down 1200.0% in 2025.
• Over 5 years, Other financing activities stood at $1.0 million in 2022, then slumped by 200.0% to -$1.0 million in 2023, then jumped by 700.0% to $6.0 million in 2024, then tumbled by 383.33% to -$17.0 million in 2025, then grew by 11.76% to -$15.0 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered -$15.0 million, -$17.0 million, and $35.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.